Related Experiment Video
Updated: Jan 9, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using
Yun Huang1, Lili Ma1, Yuyu Zhang1
1Department of Pharmacy, The Affiliated LiHuili Hospital of Ningbo University, Ningbo, Zhijiang, China.
Background:
Hypertensive heart disease is a major cause of heart failure (HF); this study evaluates the global burden and trends of HF attributable to hypertensive heart disease from 1990 to 2021.
Methods:
We collected detailed information on prevalence, years lived with disability of HF attributable to hypertensive heart disease from the Global Burden of Disease study 2021 across 204 countries and territories. Numbers, age-standardized rates, and average annual percent change of HF attributable to hypertensive heart disease prevalence and years lived with disability were compared by age, sex, and socio-demographic index.
Results:
In 1990 and 2021, hypertensive heart disease-related HF affected more than 4.6 million and 13 million individuals globally, demonstrating an age-standardized prevalence rate of 125.4 [95% uncertainty interval (UI), 99.0 to 158.0] and 148.3 per 100,000 (95% UI, 117.3-186.3) and an age-standardized years lived with disability rate of 11.2 (95% UI, 7.2-15.7) and 13.2 (95% UI, 8.4-19.1) per 100,000, respectively. Notably, from 1990 to 2021, the global age-standardized prevalence and years lived with disability rates increased consistently, with an average annual percent change of 0.53 (95% CI, 0.52-0.54) and 0.54 (95% CI, 0.53-0.55), respectively.
Conclusions:
The global burden of HF attributable to hypertensive heart disease has risen.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Hypertension II: Pathophysiology